Autophagy in PE: Dispute, Role and Potential Target

Abstract

PE is a life-threatening pregnancy disorder that can lead to adverse events for both the fetus and the mother. Autophagy is a cellular process involved in cellular renovation and maintaining homeostasis. There is a growing body of evidence suggesting that autophagy in trophoblasts plays a significant role in the development and pathogenesis of PE. However, the exact mechanisms are not yet fully understood. This article provides an overview of recent evidence regarding the role of autophagy in trophoblast invasion, vascular remodelling, inflammation, immune response, and maternal factors in the context of PE. It is believed that impaired or excessive autophagy can contribute to placental ischaemia and hypoxia, thereby exacerbating PE progression. Therefore, understanding the molecular mechanisms that regulate autophagy in PE is crucial for the development of targeted therapeutic interventions in the future.

Keywords

autophagy / immune response / inflammation / PE / placental development / trophoblast invasion / vascular remodelling

References

[1] L. C. Chappell, C. A. Cluver, J. Kingdom, and S. Tong, “Pre-Eclampsia,” Lancet 398, no. 10297 (2021): 341–354.

[2] C. W. Ives, R. Sinkey, I. Rajapreyar, A. Tita, and S. Oparil, “Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review,” Journal of the American College of Cardiology 76, no. 14 (2020): 1690–1702.

[3] F. Brownfoot and D. L. Rolnik, “Prevention of Preeclampsia,” Best Practice & Research. Clinical Obstetrics & Gynaecology 93 (2024): 102481.

[4] S. Zhou, J. Li, W. Yang, et al., “Noninvasive Preeclampsia Prediction Using Plasma Cell-Free RNA Signatures,” American Journal of Obstetrics and Gynecology 229, no. 5 (2023): 553.e1–553.e16.

[5] V. D. Garovic, R. Dechend, T. Easterling, et al., “Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association,” Hypertension 79, no. 2 (2022): e21–e41.

[6] O. Erez, R. Romero, E. Jung, et al., “Preeclampsia and Eclampsia: The Conceptual Evolution of a Syndrome,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S786–S803.

[7] E. Jung, R. Romero, L. Yeo, et al., “The Etiology of Preeclampsia,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S844–S866.

[8] P. Y. Robillard, G. Dekker, M. Scioscia, and S. Saito, “Progress in the Understanding of the Pathophysiology of Immunologic Maladaptation Related to Early-Onset Preeclampsia and Metabolic Syndrome Related to Late-Onset Preeclampsia,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S867–S875.

[9] C. Redman, A. C. Staff, and J. M. Roberts, “Syncytiotrophoblast Stress in Preeclampsia: The Convergence Point for Multiple Pathways,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S907–S927.

[10] A. Nakashima, A. Aoki, T. Kusabiraki, S. B. Cheng, S. Sharma, and S. Saito, “Autophagy Regulation in Preeclampsia: Pros and Cons,” Journal of Reproductive Immunology 123 (2017): 12317–12323.

[11] A. Nakashima, A. Furuta, M. Yoshida-Kawaguchi, et al., “Immunological Regulation and the Role of Autophagy in Preeclampsia,” American Journal of Reproductive Immunology 91, no. 3 (2024): e13835.

[12] S. Saito and A. Nakashima, “A Review of the Mechanism for Poor Placentation in Early-Onset Preeclampsia: The Role of Autophagy in Trophoblast Invasion and Vascular Remodeling,” Journal of Reproductive Immunology 101 (2014): 10280–10288.

[13] S. Y. Oh, J. R. Hwang, M. Choi, et al., “Autophagy Regulates Trophoblast Invasion by Targeting NF-κB Activity,” Scientific Reports 10, no. 1 (2020): 14033.

[14] L. Gao, H. B. Qi, K. C. Kamana, X. M. Zhang, H. Zhang, and P. N. Baker, “Excessive Autophagy Induces the Failure of Trophoblast Invasion and Vasculature: Possible Relevance to the Pathogenesis of Preeclampsia,” Journal of Hypertension 33, no. 1 (2015): 106–117.

[15] S. Banerjee, Z. Huang, Z. Wang, et al., “Etiological Value of Sterile Inflammation in Preeclampsia: Is It a Non-Infectious Pregnancy Complication,” Frontiers in Cellular and Infection Microbiology 11 (2021): 694298.

[16] R. Wan, P. Yao, Y. Wang, et al., “Autophagy-Related Biomarkers in Preeclampsia: The Underlying Mechanism, Correlation to the Immune Microenvironment and Drug Screening,” BMC Pregnancy and Childbirth 24, no. 1 (2024): 1.

[17] J. Debnath, N. Gammoh, and K. M. Ryan, “Autophagy and Autophagy-Related Pathways in Cancer,” Nature Reviews. Molecular Cell Biology 24, no. 8 (2023): 560–575.

[18] D. C. Rubinsztein, G. Mariño, and G. Kroemer, “Autophagy and Aging,” Cell 146, no. 5 (2011): 682–695.

[19] N. Mizushima and M. Komatsu, “Autophagy: Renovation of Cells and Tissues,” Cell 147, no. 4 (2011): 728–741.

[20] H. Yamamoto, S. Zhang, and N. Mizushima, “Autophagy Genes in Biology and Disease,” Nature Reviews. Genetics 24, no. 6 (2023): 382–400.

[21] A. Nakashima, A. Aoki, T. Kusabiraki, et al., “Role of Autophagy in Oocytogenesis, Embryogenesis, Implantation, and Pathophysiology of Pre-Eclampsia,” Journal of Obstetrics and Gynaecology Research 43, no. 4 (2017): 633–643.

[22] T. H. Hung, T. T. Hsieh, S. F. Chen, M. J. Li, and Y. L. Yeh, “Autophagy in the Human Placenta Throughout Gestation,” PLoS One 8, no. 12 (2013): e83475.

[23] B. Chifenti, M. T. Locci, G. Lazzeri, et al., “Autophagy-Related Protein LC3 and Beclin-1 in the First Trimester of Pregnancy,” Clinical and Experimental Reproductive Medicine 40, no. 1 (2013): 33–37.

[24] L. Avagliano, L. Terraneo, E. Virgili, et al., “Autophagy in Normal and Abnormal Early Human Pregnancies,” Reproductive Sciences 22, no. 7 (2015): 838–844.

[25] P. Signorelli, L. Avagliano, E. Virgili, et al., “Autophagy in Term Normal Human Placentas,” Placenta 32, no. 6 (2011): 482–485.

[26] S. Curtis, C. J. Jones, A. Garrod, C. H. Hulme, and A. E. Heazell, “Identification of Autophagic Vacuoles and Regulators of Autophagy in Villous Trophoblast From Normal Term Pregnancies and in Fetal Growth Restriction,” Journal of Maternal-Fetal & Neonatal Medicine 26, no. 4 (2013): 339–346.

[27] M. Gauster, S. Maninger, M. Siwetz, et al., “Downregulation of p53 Drives Autophagy During Human Trophoblast Differentiation,” Cellular and Molecular Life Sciences 75, no. 10 (2018): 1839–1855.

[28] D. Bastida-Ruiz, L. Yart, C. Wuillemin, et al., “The Fine-Tuning of Endoplasmic Reticulum Stress Response and Autophagy Activation During Trophoblast Syncytialization,” Cell Death & Disease 10, no. 9 (2019): 651.

[29] B. Cao, C. Macones, and I. U. Mysorekar, “ATG16L1 Governs Placental Infection Risk and Preterm Birth in Mice and Women,” JCI Insight 1, no. 21 (2016): e86654.

[30] L. M. Garcia-Puente, C. García-Montero, O. Fraile-Martinez, et al., “Exploring the Importance of Differential Expression of Autophagy Markers in Term Placentas From Late-Onset Preeclamptic Pregnancies,” International Journal of Molecular Sciences 25, no. 4 (2024): 2029.

[31] Q. Luo, Y. Tian, G. Qu, et al., “MiR-141-3p Promotes Hypoxia-Induced Autophagy in Human Placental Trophoblast Cells,” Reproductive Biology 23, no. 1 (2023): 100712.

[32] N. Chu, Y. Tang, C. J. Wang, et al., “ANP Promotes HTR-8/SVneo Cell Invasion by Upregulating Protein Kinase N 3 via Autophagy Inhibition,” FASEB Journal 37, no. 3 (2023): e22779.

[33] E. Öcal, V. Toprak, S. A. Akalin, F. Aşir, and E. Deveci, “Investigation of Beclin 1 and TNF-α Expressions in Preeclampsia Placentas: Immunohistochemical Study,” Medicine (Baltimore) 102, no. 33 (2023): e34757.

[34] K. Tsai, B. Tullis, T. Jensen, T. Graff, P. Reynolds, and J. Arroyo, “Differential Expression of mTOR Related Molecules in the Placenta From Gestational Diabetes Mellitus (GDM), Intrauterine Growth Restriction (IUGR) and Preeclampsia Patients,” Reproductive Biology 21, no. 2 (2021): 100503.

[35] L. Ermini, A. Farrell, S. Alahari, et al., “Ceramide-Induced Lysosomal Biogenesis and Exocytosis in Early-Onset Preeclampsia Promotes Exosomal Release of SMPD1 Causing Endothelial Dysfunction,” Frontiers in Cell and Development Biology 9 (2021): 652651.

[36] J. Ausman, J. Abbade, L. Ermini, et al., “Ceramide-Induced BOK Promotes Mitochondrial Fission in Preeclampsia,” Cell Death & Disease 9, no. 3 (2018): 298.

[37] Y. J. Pan, L. He, S. J. Zhou, L. J. Zhang, A. H. Zhang, and Y. Y. Zhao, “Expression of Urotensin II Is Associated With Placental Autophagy in Patients With Severe Preeclampsia,” Journal of Human Hypertension 32, no. 11 (2018): 759–769.

[38] Y. Xu, X. Huang, J. Xie, Y. Chen, J. Fu, and L. Wang, “Let-7i-Induced Atg4B Suppression Is Essential for Autophagy of Placental Trophoblast in Preeclampsia,” Journal of Cellular Physiology 232, no. 9 (2017): 2581–2589.

[39] D. Akcora Yildiz, S. Irtegun Kandemir, E. Agacayak, and E. Deveci, “Evaluation of Protein Levels of Autophagy Markers (Beclin 1 and SQSTM1/p62) and Phosphorylation of Cyclin E in the Placenta of Women With Preeclampsia,” Cellular and Molecular Biology (Noisy-le-Grand, France) 63, no. 12 (2017): 51–55.

[40] M. Hutabarat, N. Wibowo, and B. Huppertz, “The Trophoblast Survival Capacity in Preeclampsia,” PLoS One 12, no. 11 (2017): e0186909.

[41] A. Prokesch, A. Blaschitz, T. Bauer, et al., “Placental DAPK1 and Autophagy Marker LC3B-II Are Dysregulated by TNF-α in a Gestational Age-Dependent Manner,” Histochemistry and Cell Biology 147, no. 6 (2017): 695–705.

[42] R. Akaishi, T. Yamada, K. Nakabayashi, et al., “Autophagy in the Placenta of Women With Hypertensive Disorders in Pregnancy,” Placenta 35, no. 12 (2014): 974–980.

[43] M. Kalkat, J. Garcia, J. Ebrahimi, et al., “Placental Autophagy Regulation by the BOK-MCL1 Rheostat,” Autophagy 9, no. 12 (2013): 2140–2153.

[44] S. Y. Oh, S. J. Choi, K. H. Kim, E. Y. Cho, J. H. Kim, and C. R. Roh, “Autophagy-Related Proteins, LC3 and Beclin-1, in Placentas From Pregnancies Complicated by Preeclampsia,” Reproductive Sciences 15, no. 9 (2008): 912–920.

[45] Y. Sun, D. Lv, Y. Xie, et al., “PINK1-Mediated Mitophagy Induction Protects Against Preeclampsia by Decreasing ROS and Trophoblast Pyroptosis,” Placenta 143 (2023): 1431.

[46] I. C. Weel, V. R. Ribeiro, M. Romão-Veiga, E. G. Fioratti, J. C. Peraçoli, and M. Peraçoli, “Down-Regulation of Autophagy Proteins Is Associated With Higher mTOR Expression in the Placenta of Pregnant Women With Preeclampsia,” Brazilian Journal of Medical and Biological Research 55 (2023): e12283.

[47] V. R. Ribeiro, M. Romao-Veiga, P. R. Nunes, J. C. Peracoli, and M. Peracoli, “Increase of Autophagy Marker p62 in the Placenta From Pregnant Women With Preeclampsia,” Human Immunology 83, no. 5 (2022): 447–452.

[48] S. Cheng, Z. Huang, S. Banerjee, S. Jash, J. N. Buxbaum, and S. Sharma, “Evidence From Human Placenta, Endoplasmic Reticulum-Stressed Trophoblasts, and Transgenic Mice Links Transthyretin Proteinopathy to Preeclampsia,” Hypertension 79, no. 8 (2022): 1738–1754.

[49] X. Zhou, X. Zhao, W. Zhou, et al., “Impaired Placental Mitophagy and Oxidative Stress Are Associated With Dysregulated BNIP3 in Preeclampsia,” Scientific Reports 11, no. 1 (2021): 20469.

[50] P. Vangrieken, S. Al-Nasiry, A. Bast, et al., “Placental Mitochondrial Abnormalities in Preeclampsia,” Reproductive Sciences 28, no. 8 (2021): 2186–2199.

[51] Y. Li, X. Zhao, B. He, et al., “Autophagy Activation by Hypoxia Regulates Angiogenesis and Apoptosis in Oxidized Low-Density Lipoprotein-Induced Preeclampsia,” Frontiers in Molecular Biosciences 8 (2021): 8709751.

[52] A. Nakashima, S. B. Cheng, M. Ikawa, et al., “Evidence for Lysosomal Biogenesis Proteome Defect and Impaired Autophagy in Preeclampsia,” Autophagy 16, no. 10 (2020): 1771–1785.

[53] A. Z. Ozsoy, S. Cayli, C. Sahin, S. Ocakli, Sanci TO, and D. B. Ilhan, “Altered Expression of p97/Valosin Containing Protein and Impaired Autophagy in Preeclamptic Human Placenta,” Placenta 67 (2018): 45–53.

[54] A. Nakashima, M. Yamanaka-Tatematsu, N. Fujita, et al., “Impaired Autophagy by Soluble Endoglin, Under Physiological Hypoxia in Early Pregnant Period, Is Involved in Poor Placentation in Preeclampsia,” Autophagy 9, no. 3 (2013): 303–316.

[55] A. Nakashima, S. Tsuda, T. Kusabiraki, et al., “Current Understanding of Autophagy in Pregnancy,” International Journal of Molecular Sciences 20, no. 9 (2019): 2342.

[56] S. Cheng, Z. Huang, S. Jash, et al., “Hypoxia-Reoxygenation Impairs Autophagy-Lysosomal Machinery in Primary Human Trophoblasts Mimicking Placental Pathology of Early-Onset Preeclampsia,” International Journal of Molecular Sciences 23, no. 10 (2022): 5644.

[57] D. Goldman-Wohl, T. Cesla, Y. Smith, et al., “Expression Profiling of Autophagy Associated Genes in Placentas of Preeclampsia,” Placenta 34, no. 10 (2013): 959–962.

[58] Z. Li, S. Wang, and L. Li, “Advanced Oxidative Protein Products Drive Trophoblast Cells Into Senescence by Inhibiting the Autophagy: The Potential Implication of Preeclampsia,” Frontiers in Cell and Development Biology 10 (2022): 810282.

[59] A. Tarrade, R. Lai Kuen, A. Malassiné, et al., “Characterization of Human Villous and Extravillous Trophoblasts Isolated From First Trimester Placenta,” Laboratory Investigation 81, no. 9 (2001): 1199–1211.

[60] Q. Yang, Y. Ma, Y. Liu, et al., “MNSFβ Regulates Placental Development by Conjugating IGF2BP2 to Enhance Trophoblast Cell Invasiveness,” Cell Proliferation 54, no. 12 (2021): e13145.

[61] A. C. Staff, H. E. Fjeldstad, I. K. Fosheim, et al., “Failure of Physiological Transformation and Spiral Artery Atherosis: Their Roles in Preeclampsia,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S895–S906.

[62] N. He, L. van Iperen, D. de Jong, et al., “Human Extravillous Trophoblasts Penetrate Decidual Veins and Lymphatics Before Remodeling Spiral Arteries During Early Pregnancy,” PLoS One 12, no. 1 (2017): e0169849.

[63] Y. Ma, X. Yu, S. Ye, et al., “Immune-Regulatory Properties of Endovascular Extravillous Trophoblast Cells in Human Placenta,” Placenta 145 (2024): 107–116.

[64] Y. Ma, Q. Yang, M. Fan, et al., “Placental Endovascular Extravillous Trophoblasts (enEVTs) Educate Maternal T-Cell Differentiation Along the Maternal-Placental Circulation,” Cell Proliferation 53, no. 5 (2020): e12802.

[65] I. Caniggia, H. Mostachfi, J. Winter, et al., “Hypoxia-Inducible Factor-1 Mediates the Biological Effects of Oxygen on Human Trophoblast Differentiation Through TGFbeta(3),” Journal of Clinical Investigation 105, no. 5 (2000): 577–587.

[66] Y. Yi, J. C. Cheng, C. Klausen, and P. Leung, “TGF-β1 Inhibits Human Trophoblast Cell Invasion by Upregulating Cyclooxygenase-2,” Placenta 68 (2018): 44–51.

[67] A. Aoki, A. Nakashima, T. Kusabiraki, et al., “Trophoblast-Specific Conditional Atg7 Knockout Mice Develop Gestational Hypertension,” American Journal of Pathology 188, no. 11 (2018): 2474–2486.

[68] S. Shigeru and N. Akitoshi, “Impaired Autophagy in Extravillous Trophoblast May Induce Poor Placentation in Preeclampsia,” Pregnancy Hypertension 3, no. 2 (2013): 65–66.

[69] Y. Zhou, M. J. Gormley, N. M. Hunkapiller, et al., “Reversal of Gene Dysregulation in Cultured Cytotrophoblasts Reveals Possible Causes of Preeclampsia,” Journal of Clinical Investigation 123, no. 7 (2013): 2862–2872.

[70] L. Wang, Y. Zhang, H. Qu, et al., “Reduced ELABELA Expression Attenuates Trophoblast Invasion Through the PI3K/AKT/mTOR Pathway in Early Onset Preeclampsia,” Placenta 87 (2019): 38–45.

[71] J. Chen, C. Yue, J. Xu, et al., “Downregulation of Receptor Tyrosine Kinase-Like Orphan Receptor 1 in Preeclampsia Placenta Inhibits Human Trophoblast Cell Proliferation, Migration, and Invasion by PI3K/AKT/mTOR Pathway Accommodation,” Placenta 82 (2019): 17–24.

[72] C. Yin, J. Wang, Y. Zhang, et al., “Death Receptor 3 Is Involved in Preeclampsia Through Regulating Placental Trophoblast Cell Physiology by Inactivating the PI3K/AKT Pathway,” Immunity, Inflammation and Disease 11, no. 9 (2023): e995.

[73] H. Dai and X. Lu, “MGST1 Alleviates the Oxidative Stress of Trophoblast Cells Induced by Hypoxia/Reoxygenation and Promotes Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT/mTOR Pathway,” Open Med (Wars) 17, no. 1 (2022): 2062–2071.

[74] M. Chen, B. Chao, J. Xu, et al., “CPT1A Modulates PI3K/Akt/mTOR Pathway to Promote Preeclampsia,” Placenta 133 (2023): 23–31.

[75] Y. Li, X. L. Sun, C. L. Ma, et al., “STX2 Promotes Trophoblast Growth, Migration, and Invasion Through Activation of the PI3K-AKT Pathway in Preeclampsia,” Frontiers in Cell and Development Biology 9 (2021): 615973.

[76] Y. Xu, L. Sui, B. Qiu, X. Yin, J. Liu, and X. Zhang, “ANXA4 Promotes Trophoblast Invasion via the PI3K/Akt/eNOS Pathway in Preeclampsia,” American Journal of Physiology. Cell Physiology 316, no. 4 (2019): C481–C491.

[77] P. Xu, Y. Zheng, J. Liao, et al., “AMPK Regulates Homeostasis of Invasion and Viability in Trophoblasts by Redirecting Glucose Metabolism: Implications for Pre-Eclampsia,” Cell Proliferation 56, no. 2 (2023): e13358.

[78] H. Zhao, R. J. Wong, and D. K. Stevenson, “The Impact of Hypoxia in Early Pregnancy on Placental Cells,” International Journal of Molecular Sciences 22, no. 18 (2021): 9675.

[79] J. H. Choi, H. J. Lee, T. H. Yang, and G. J. Kim, “Effects of Hypoxia Inducible Factors-1α on Autophagy and Invasion of Trophoblasts,” Clinical and Experimental Reproductive Medicine 39, no. 2 (2012): 73–80.

[80] L. Li, W. Peng, Q. Zhou, J. P. Wan, X. T. Wang, and H. B. Qi, “LRP6 Regulates Rab7-Mediated Autophagy Through the Wnt/β-Catenin Pathway to Modulate Trophoblast Cell Migration and Invasion,” Journal of Cellular Biochemistry 121, no. 2 (2020): 1599–1609.

[81] G. Meinhardt, S. Haider, P. Haslinger, et al., “Wnt-Dependent T-Cell Factor-4 Controls Human Etravillous Trophoblast Motility,” Endocrinology 155, no. 5 (2014): 1908–1920.

[82] S. Sonderegger, J. Pollheimer, and M. Knöfler, “Wnt Signalling in Implantation, Decidualisation and Placental Differentiation–Review,” Placenta 31, no. 10 (2010): 839–847.

[83] M. Yamanaka-Tatematsu, A. Nakashima, N. Fujita, T. Shima, T. Yoshimori, and S. Saito, “Autophagy Induced by HIF1α Overexpression Supports Trophoblast Invasion by Supplying Cellular Energy,” PLoS One 8, no. 10 (2013): e76605.

[84] K. M. Varberg, E. M. Dominguez, B. Koseva, et al., “Extravillous Trophoblast Cell Lineage Development Is Associated With Active Remodeling of the Chromatin Landscape,” Nature Communications 14, no. 1 (2023): 4826.

[85] R. Pijnenborg, L. Vercruysse, and M. Hanssens, “The Uterine Spiral Arteries in Human Pregnancy: Facts and Controversies,” Placenta 27, no. 9–10 (2006): 939–958.

[86] I. Brosens, P. Puttemans, and G. Benagiano, “Placental Bed Research: I. The Placental Bed: From Spiral Arteries Remodeling to the Great Obstetrical Syndromes,” American Journal of Obstetrics and Gynecology 221, no. 5 (2019): 437–456.

[87] I. Brosens, “A Study of the Spiral Arteries of the Decidua Basalis in Normotensive and Hypertensive Pregnancies,” Journal of Obstetrics and Gynaecology of the British Commonwealth 71 (1964): 222–230.

[88] I. A. Brosens, W. B. Robertson, and H. G. Dixon, “The Role of the Spiral Arteries in the Pathogenesis of Preeclampsia,” Obstetrics and Gynecology Annual 1 (1972): 177–191.

[89] H. Ren, R. Dai, W. N. Nik Nabil, Z. Xi, F. Wang, and H. Xu, “Unveiling the Dual Role of Autophagy in Vascular Remodelling and Its Related Diseases,” Biomedicine & Pharmacotherapy 168 (2023): 115643.

[90] B. Lee, H. Shin, J. E. Oh, et al., “An Autophagic Deficit in the Uterine Vessel Microenvironment Provokes Hyperpermeability Through Deregulated VEGFA, NOS1, and CTNNB1,” Autophagy 17, no. 7 (2021): 1649–1666.

[91] H. Zhao, L. Gong, S. Wu, et al., “The Inhibition of Protein Kinase C β Contributes to the Pathogenesis of Preeclampsia by Activating Autophagy,” eBioMedicine 56 (2020): 102813.

[92] E. Steingrímsson, L. Tessarollo, S. W. Reid, N. A. Jenkins, and N. G. Copeland, “The bHLH-Zip Transcription Factor Tfeb Is Essential for Placental Vascularization,” Development 125, no. 23 (1998): 4607–4616.

[93] S. Z. McIntosh, M. M. Maestas, J. R. Dobson, K. E. Quinn, C. L. Runyan, and R. L. Ashley, “CXCR4 Signaling at the Fetal-Maternal Interface May Drive Inflammation and Syncytia Formation During Ovine Pregnancy†,” Biology of Reproduction 104, no. 2 (2021): 468–478.

[94] M. C. Álvarez-Cabrera, E. Barrientos-Galeana, A. Barrera-García, et al., “Secretion of Heat Shock −60, −70 kD Protein, IL-1β and TNFα Levels in Serum of a Term Normal Pregnancy and Patients With Pre-Eclampsia Development,” Journal of Cellular and Molecular Medicine 22, no. 11 (2018): 5748–5752.

[95] A. Sharma, A. Satyam, and J. B. Sharma, “Leptin, IL-10 and Inflammatory Markers (TNF-Alpha, IL-6 and IL-8) in Pre-Eclamptic, Normotensive Pregnant and Healthy Non-Pregnant Women,” American Journal of Reproductive Immunology 58, no. 1 (2007): 21–30.

[96] D. Sharma, A. Singh, S. S. Trivedi, and J. Bhattacharjee, “Role of Endothelin and Inflammatory Cytokines in Pre-Eclampsia - A Pilot North Indian Study,” American Journal of Reproductive Immunology 65, no. 4 (2011): 428–432.

[97] T. Spence, P. J. Allsopp, A. J. Yeates, M. S. Mulhern, J. J. Strain, and E. M. McSorley, “Maternal Serum Cytokine Concentrations in Healthy Pregnancy and Preeclampsia,” Journal of Pregnancy 2021 (2021): 6649608.

[98] A. Szarka, J. Rigó,, L. Lázár, G. Beko, and A. Molvarec, “Circulating Cytokines, Chemokines and Adhesion Molecules in Normal Pregnancy and Preeclampsia Determined by Multiplex Suspension Array,” BMC Immunology 11 (2010): 59.

[99] A. C. Harmon, D. C. Cornelius, L. M. Amaral, et al., “The Role of Inflammation in the Pathology of Preeclampsia,” Clinical Science (London, England) 130, no. 6 (2016): 409–419.

[100] C. W. Redman, G. P. Sacks, and I. L. Sargent, “Preeclampsia: An Excessive Maternal Inflammatory Response to Pregnancy,” American Journal of Obstetrics and Gynecology 180, no. 2 Pt 1 (1999): 499–506.

[101] B. Schiessl, “Inflammatory Response in Preeclampsia,” Molecular Aspects of Medicine 28, no. 2 (2007): 210–219.

[102] M. W. Socha, B. Malinowski, O. Puk, M. Dubiel, and M. Wiciński, “The NLRP3 Inflammasome Role in the Pathogenesis of Pregnancy Induced Hypertension and Preeclampsia,” Cells 9, no. 7 (2020): 1642.

[103] Y. Wang, L. L. Liu, Y. Tian, et al., “Upregulation of DAPK2 Ameliorates Oxidative Damage and Apoptosis of Placental Cells in Hypertensive Disorder Complicating Pregnancy by Suppressing Human Placental Microvascular Endothelial Cell Autophagy Through the mTOR Signaling Pathway,” International Journal of Biological Macromolecules 121 (2019): 488–497.

[104] H. Wu, K. Liu, and J. Zhang, “Excess Fibronectin 1 Participates in Pathogenesis of Pre-Eclampsia by Promoting Apoptosis and Autophagy in Vascular Endothelial Cells,” Molecular Human Reproduction 27, no. 6 (2021): gaab030.

[105] D. I. Chiarello, C. Abad, D. Rojas, et al., “Oxidative Stress: Normal Pregnancy Versus Preeclampsia,” Biochimica et Biophysica Acta - Molecular Basis of Disease 1866, no. 2 (2020): 165354.

[106] M. Redza-Dutordoir and D. A. Averill-Bates, “Interactions Between Reactive Oxygen Species and Autophagy: Special Issue: Death Mechanisms in Cellular Homeostasis,” Biochimica et Biophysica Acta, Molecular Cell Research 1868, no. 8 (2021): 119041.

[107] F. He, X. Ru, and T. Wen, “NRF2, a Transcription Factor for Stress Response and Beyond,” International Journal of Molecular Sciences 21, no. 13 (2020): 4777.

[108] D. Wu, X. Chen, L. Wang, F. Chen, H. Cen, and L. Shi, “Hypoxia-Induced MicroRNA-141 Regulates Trophoblast Apoptosis, Invasion, and Vascularization by Blocking CXCL12β/CXCR2/4 Signal Transduction,” Biomedicine & Pharmacotherapy 116 (2019): 108836.

[109] S. W. Ryter, H. P. Kim, A. Hoetzel, et al., “Mechanisms of Cell Death in Oxidative Stress,” Antioxidants & Redox Signaling 9, no. 1 (2007): 49–89.

[110] K. Kannan and S. K. Jain, “Oxidative Stress and Apoptosis,” Pathophysiology 7, no. 3 (2000): 153–163.

[111] A. W. Lokeswara, R. Hiksas, R. Irwinda, and N. Wibowo, “Preeclampsia: From Cellular Wellness to Inappropriate Cell Death, and the Roles of Nutrition,” Frontiers in Cell and Development Biology 9 (2021): 726513.

[112] R. Aouache, L. Biquard, D. Vaiman, and F. Miralles, “Oxidative Stress in Preeclampsia and Placental Diseases,” International Journal of Molecular Sciences 19, no. 5 (2018): 1496.

[113] R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, “The Beclin 1 Network Regulates Autophagy and Apoptosis,” Cell Death and Differentiation 18, no. 4 (2011): 571–580.

[114] S. Naim and T. Kaufmann, “The Multifaceted Roles of the BCL-2 Family Member BOK,” Frontiers in Cell and Development Biology 8 (2020): 574338.

[115] J. M. Rodriguez, M. A. Glozak, Y. Ma, and W. D. Cress, “Bok, Bcl-2-Related Ovarian Killer, Is Cell Cycle-Regulated and Sensitizes to Stress-Induced Apoptosis,” Journal of Biological Chemistry 281, no. 32 (2006): 22729–22735.

[116] D. Yuan, Z. Yang, Y. Chen, S. Li, B. Tan, and Q. Yu, “Hypoxia-Induced SPOP Attenuates the Mobility of Trophoblast Cells Through Inhibition of the PI3K/AKT/GSK3β Pathway,” Cell Biology International 45, no. 3 (2021): 599–611.

[117] M. Ye, T. Liu, S. Liu, et al., “Peroxiredoxin 1 Regulates Crosstalk Between Pyroptosis and Autophagy in Oral Squamous Cell Carcinoma Leading to a Potential Pro-Survival,” Cell Death Discovery 9, no. 1 (2023): 425.

[118] X. Guo, D. Dilidaxi, L. Li, et al., “Aspirin Protects Human Trophoblast HTR-8/SVneo Cells From H(2)O(2)-Induced Oxidative Stress via NADPH/ROS Pathway,” Placenta 144 (2023): 55–63.

[119] D. X. Fu, Y. T. Lei, H. B. Guo, et al., “PRDX1 Affects Acrylamide-Induced Neural Damage Through the PTEN/AKT Signaling Pathway,” Neurotoxicology 108 (2025): 150–158.

[120] E. Guzel, S. Arlier, O. Guzeloglu-Kayisli, et al., “Endoplasmic Reticulum Stress and Homeostasis in Reproductive Physiology and Pathology,” International Journal of Molecular Sciences 18, no. 4 (2017): 792.

[121] G. J. Burton and H. W. Yung, “Endoplasmic Reticulum Stress in the Pathogenesis of Early-Onset Pre-Eclampsia,” Pregnancy Hypertension 1, no. 1–2 (2011): 72–78.

[122] A. Nakashima, S. B. Cheng, T. Kusabiraki, et al., “Endoplasmic Reticulum Stress Disrupts Lysosomal Homeostasis and Induces Blockade of Autophagic Flux in Human Trophoblasts,” Scientific Reports 9, no. 1 (2019): 11466.

[123] M. Mizuuchi, T. Cindrova-Davies, M. Olovsson, D. S. Charnock-Jones, G. J. Burton, and H. W. Yung, “Placental Endoplasmic Reticulum Stress Negatively Regulates Transcription of Placental Growth Factor via ATF4 and ATF6β: Implications for the Pathophysiology of Human Pregnancy Complications,” Journal of Pathology 238, no. 4 (2016): 550–561.

[124] A. Khaminets, T. Heinrich, M. Mari, et al., “Regulation of Endoplasmic Reticulum Turnover by Selective Autophagy,” Nature 522, no. 7556 (2015): 354–358.

[125] W. Zhang, X. Chen, Z. Yan, et al., “Detergent-Insoluble Proteome Analysis Revealed Aberrantly Aggregated Proteins in Human Preeclampsia Placentas,” Journal of Proteome Research 16, no. 12 (2017): 4468–4480.

[126] I. A. Buhimschi, U. A. Nayeri, G. Zhao, et al., “Protein Misfolding, Congophilia, Oligomerization, and Defective Amyloid Processing in Preeclampsia,” Science Translational Medicine 6, no. 245 (2014): 245ra92.

[127] S. Kalkunte, R. Boij, W. Norris, et al., “Sera From Preeclampsia Patients Elicit Symptoms of Human Disease in Mice and Provide a Basis for an In Vitro Predictive Assay,” American Journal of Pathology 177, no. 5 (2010): 2387–2398.

[128] L. Secomandi, M. Borghesan, M. Velarde, and M. Demaria, “The Role of Cellular Senescence in Female Reproductive Aging and the Potential for Senotherapeutic Interventions,” Human Reproduction Update 28, no. 2 (2022): 172–189.

[129] A. M. Nuzzo, D. Giuffrida, B. Masturzo, et al., “Altered Expression of G1/S Phase Cell Cycle Regulators in Placental Mesenchymal Stromal Cells Derived From Preeclamptic Pregnancies With Fetal-Placental Compromise,” Cell Cycle 16, no. 2 (2017): 200–212.

[130] E. Deer, O. Herrock, N. Campbell, et al., “The Role of Immune Cells and Mediators in Preeclampsia,” Nature Reviews. Nephrology 19, no. 4 (2023): 257–270.

[131] X. Zhang and H. Wei, “Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications,” Frontiers in Immunology 12 (2021): 728291.

[132] H. X. Tan, S. L. Yang, M. Q. Li, and H. Y. Wang, “Autophagy Suppression of Trophoblast Cells Induces Pregnancy Loss by Activating Decidual NK Cytotoxicity and Inhibiting Trophoblast Invasion,” Cell Communication and Signaling: CCS 18, no. 1 (2020): 73.

[133] N. Liu, H. Shen, Z. Wang, X. Qin, M. Li, and X. Zhang, “Autophagy Inhibition in Trophoblasts Induces Aberrant Shift in CXCR4(+) Decidual NK Cell Phenotype Leading to Pregnancy Loss,” Journal of Clinical Medicine 12, no. 23 (2023): 7491.

[134] J. Liu, G. Song, T. Meng, and G. Zhao, “UL16-Binding Protein 1 Induced HTR-8/SVneo Autophagy via NF-κB Suppression Mediated by TNF-α Secreted Through uNK Cells,” BioMed Research International 2020 (2020): 9280372.

[135] T. E. O'Sullivan, C. D. Geary, O. E. Weizman, et al., “Atg5 Is Essential for the Development and Survival of Innate Lymphocytes,” Cell Reports 15, no. 9 (2016): 1910–1919.

[136] H. Lu, H. L. Yang, W. J. Zhou, et al., “Rapamycin Prevents Spontaneous Abortion by Triggering Decidual Stromal Cell Autophagy-Mediated NK Cell Residence,” Autophagy 17, no. 9 (2021): 2511–2527.

[137] L. K. Harris, M. Benagiano, M. M. D'Elios, I. Brosens, and G. Benagiano, “Placental Bed Research: II. Functional and Immunological Investigations of the Placental Bed,” American Journal of Obstetrics and Gynecology 221, no. 5 (2019): 457–469.

[138] F. Sun, S. Wang, and M. Du, “Functional Regulation of Decidual Macrophages During Pregnancy,” Journal of Reproductive Immunology 143 (2021): 103264.

[139] N. Germic, Z. Frangez, S. Yousefi, and H. U. Simon, “Regulation of the Innate Immune System by Autophagy: Monocytes, Macrophages, Dendritic Cells and Antigen Presentation,” Cell Death and Differentiation 26, no. 4 (2019): 715–727.

[140] T. Saitoh, N. Fujita, M. H. Jang, et al., “Loss of the Autophagy Protein Atg16L1 Enhances Endotoxin-Induced IL-1beta Production,” Nature 456, no. 7219 (2008): 264–268.

[141] Y. Yao, X. H. Xu, and L. Jin, “Macrophage Polarization in Physiological and Pathological Pregnancy,” Frontiers in Immunology 10 (2019): 792.

[142] M. X. Tang, X. H. Hu, Z. Z. Liu, J. Kwak-Kim, and A. H. Liao, “What Are the Roles of Macrophages and Monocytes in Human Pregnancy,” Journal of Reproductive Immunology 112 (2015): 273–280.

[143] P. Vishnyakova, A. Elchaninov, T. Fatkhudinov, and G. Sukhikh, “Role of the Monocyte-Macrophage System in Normal Pregnancy and Preeclampsia,” International Journal of Molecular Sciences 20, no. 15 (2019): 3695.

[144] J. Jin, L. Gao, X. Zou, et al., “Gut Dysbiosis Promotes Preeclampsia by Regulating Macrophages and Trophoblasts,” Circulation Research 131, no. 6 (2022): 492–506.

[145] Y. Yang, H. Liu, Y. Zhao, C. Geng, L. Chao, and A. Hao, “Grim-19 Deficiency Promotes Decidual Macrophage Autophagy in Recurrent Spontaneous Abortion,” Frontiers in Endocrinology 13 (2022): 1023194.

[146] S. Ghafouri-Fard, H. Shoorei, M. Mohaqiq, J. Majidpoor, M. A. Moosavi, and M. Taheri, “Exploring the Role of Non-Coding RNAs in Autophagy,” Autophagy 18, no. 5 (2022): 949–970.

[147] N. Jørgensen, G. Persson, and T. Hviid, “The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer,” Frontiers in Immunology 10 (2019): 911.

[148] J. Dengjel, O. Schoor, R. Fischer, et al., “Autophagy Promotes MHC Class II Presentation of Peptides From Intracellular Source Proteins,” Proceedings of the National Academy of Sciences of the United States of America 102, no. 22 (2005): 7922–7927.

[149] G. Yang, W. Song, J. L. Postoak, et al., “Autophagy-Related Protein PIK3C3/VPS34 Controls T Cell Metabolism and Function,” Autophagy 17, no. 5 (2021): 1193–1204.

[150] G. Cao, M. Lin, W. Gu, et al., “The Rules and Regulatory Mechanisms of FOXO3 on Inflammation, Metabolism, Cell Death and Aging in Hosts,” Life Sciences 328 (2023): 121877.

[151] G. Filomeni, D. De Zio, and F. Cecconi, “Oxidative Stress and Autophagy: The Clash Between Damage and Metabolic Needs,” Cell Death and Differentiation 22, no. 3 (2015): 377–388.

[152] J. Wei, L. Long, K. Yang, et al., “Autophagy Enforces Functional Integrity of Regulatory T Cells by Coupling Environmental Cues and Metabolic Homeostasis,” Nature Immunology 17, no. 3 (2016): 277–285.

[153] J. Zhang, L. Chen, F. Xiong, et al., “Autophagy in Regulatory T Cells: A Double-Edged Sword in Disease Settings,” Molecular Immunology 109 (2019): 43–50.

[154] E. L. Eskelinen and P. Saftig, “Autophagy: A Lysosomal Degradation Pathway With a Central Role in Health and Disease,” Biochimica et Biophysica Acta 1793, no. 4 (2009): 664–673.

[155] Y. Lei and D. J. Klionsky, “Transcriptional Regulation of Autophagy and Its Implications in Human Disease,” Cell Death and Differentiation 30, no. 6 (2023): 1416–1429.

[156] A. C. Staff, “The Two-Stage Placental Model of Preeclampsia: An Update,” Journal of Reproductive Immunology 134 (2019): 1–10.

[157] S. Muralimanoharan, X. Gao, S. Weintraub, L. Myatt, and A. Maloyan, “Sexual Dimorphism in Activation of Placental Autophagy in Obese Women With Evidence for Fetal Programming From a Placenta-Specific Mouse Model,” Autophagy 12, no. 5 (2016): 752–769.

[158] M. Cohen, E. Guo, A. Pucchio, B. de Vrijer, T. G. Shepherd, and G. Eastabrook, “Maternal Obesity Reduces Placental Autophagy Marker Expression in Uncomplicated Pregnancies,” Journal of Obstetrics and Gynaecology Research 46, no. 8 (2020): 1282–1291.

[159] Y. Nakabayashi, A. Nakashima, O. Yoshino, et al., “Impairment of the Accumulation of Decidual T Cells, NK Cells, and Monocytes, and the Poor Vascular Remodeling of Spiral Arteries, Were Observed in Oocyte Donation Cases, Regardless of the Presence or Absence of Preeclampsia,” Journal of Reproductive Immunology 114 (2016): 65–74.

[160] V. Giorgione, A. Bhide, R. Bhate, K. Reed, and A. Khalil, “Are Twin Pregnancies Complicated by Weight Discordance or Fetal Growth Restriction at Higher Risk of Preeclampsia,” Journal of Clinical Medicine 9, no. 10 (2020): 3276.

[161] Q. Mao, S. Chu, S. Shapiro, H. Yao, and M. E. De Paepe, “Discordant Placental Oxygenation and Autophagy in Twin Anemia-Polycythemia Sequence (TAPS),” Placenta 90 (2020): 9–17.

[162] W. Fan, W. Zhou, Q. Yan, et al., “Upregulation of METTL14 Contributes to Trophoblast Dysfunction by Elevating FOXO3a Expression in an m(6)A-Dependent Manner,” Placenta 124 (2022): 18–27.

[163] Z. Yu, T. Yu, X. Li, et al., “Cadmium Exposure Activates Mitophagy Through Downregulating Thyroid Hormone Receptor/PGC1α Signal in Preeclampsia,” Ecotoxicology and Environmental Safety 276 (2024): 116–259.

[164] H. Li, D. Miao, H. Hu, P. Xue, K. Zhou, and Z. Mao, “Titanium Dioxide Nanoparticles Induce Maternal Preeclampsia-Like Syndrome and Adverse Birth Outcomes via Disrupting Placental Function in SD Rats,” Toxics 12, no. 5 (2024): 367.

[165] X. Yin, R. Gao, Y. Geng, et al., “Autophagy Regulates Abnormal Placentation Induced by Folate Deficiency in Mice,” Molecular Human Reproduction 25, no. 6 (2019): 305–319.

[166] S. Lee, J. Shin, J. S. Kim, J. Shin, S. K. Lee, and H. W. Park, “Targeting TBK1 Attenuates LPS-Induced NLRP3 Inflammasome Activation by Regulating of mTORC1 Pathways in Trophoblasts,” Frontiers in Immunology 12 (2021): 743700.

[167] A. C. Eddy, C. Y. Chiang, A. Rajakumar, et al., “Bioflavonoid Luteolin Prevents sFlt-1 Release via HIF-1α Inhibition in Cultured Human Placenta,” FASEB Journal 37, no. 8 (2023): e23078.

[168] H. Hu, W. Chen, Z. Tao, et al., “Cyclosporin A Alleviates Trophoblast Apoptosis and Senescence by Promoting Autophagy in Preeclampsia,” Placenta 117 (2022): 95–108.

[169] J. Pei, Z. Liu, C. Wang, et al., “Progesterone Attenuates SIRT1-Deficiency-Mediated Pre-Eclampsia,” Biomolecules 12, no. 3 (2022): 422.

[170] S. Gu, C. Zhou, J. Pei, et al., “Esomeprazole Inhibits Hypoxia/Endothelial Dysfunction-Induced Autophagy in Preeclampsia,” Cell and Tissue Research 388, no. 1 (2022): 181–194.

[171] H. R. Kohan-Ghadr, B. Armistead, M. Berg, and S. Drewlo, “Irisin Protects the Human Placenta From Oxidative Stress and Apoptosis via Activation of the Akt Signaling Pathway,” International Journal of Molecular Sciences 22, no. 20 (2021): 11229.

[172] Y. Yuan, L. Zhao, X. Wang, F. Lian, and Y. Cai, “Ligustrazine-Induced microRNA-16-5p Inhibition Alleviates Preeclampsia Through IGF-2,” Reproduction 160, no. 6 (2020): 905–917.

[173] Y. Chu, C. Zhu, C. Yue, et al., “Chorionic Villus-Derived Mesenchymal Stem Cell-Mediated Autophagy Promotes the Proliferation and Invasiveness of Trophoblasts Under Hypoxia by Activating the JAK2/STAT3 Signalling Pathway,” Cell & Bioscience 11, no. 1 (2021): 182.

[174] L. Sagrillo-Fagundes, E. M. Assunção Salustiano, R. Ruano, R. P. Markus, and C. Vaillancourt, “Melatonin Modulates Autophagy and Inflammation Protecting Human Placental Trophoblast From Hypoxia/Reoxygenation,” Journal of Pineal Research 65, no. 4 (2018): e12520.

[175] Y. Chu, W. Chen, W. Peng, et al., “Amnion-Derived Mesenchymal Stem Cell Exosomes-Mediated Autophagy Promotes the Survival of Trophoblasts Under Hypoxia Through mTOR Pathway by the Downregulation of EZH2,” Frontiers in Cell and Development Biology 8 (2020): 545852.

[176] Y. Ju, Y. Feng, X. Hou, et al., “Combined Apocyanin and Aspirin Treatment Activates the PI3K/Nrf2/HO-1 Signaling Pathway and Ameliorates Preeclampsia Symptoms in Rats,” Hypertension in Pregnancy 41, no. 1 (2022): 39–50.

[177] L. Xue, K. Xie, L. Wu, et al., “A Novel Peptide Relieves Endothelial Cell Dysfunction in Preeclampsia by Regulating the PI3K/mTOR/HIF1α Pathway,” International Journal of Molecular Medicine 47, no. 1 (2021): 276–288.

[178] H. Liu, L. Yu, Y. Ding, M. Peng, and Y. Deng, “Progesterone Enhances the Invasion of Trophoblast Cells by Activating PI3K/AKT Signaling Pathway to Prevent Preeclampsia,” Cell Transplantation 32 (2023): 9636897221145682.

[179] D. Chen, S. Yang, J. Ding, and A. Liu, “Natural Flavonoid Quercetin Enhances the Anti-Inflammatory Effects of Aspirin in a Preeclampsia-Like Rat Model Induced by Lipopolysaccharide,” Current Molecular Medicine 23, no. 5 (2023): 425–432.

[180] Y. H. Yi, Z. Yang, Y. W. Han, and J. Huai, “Effects of Rapamycin on Clinical Manifestations and Blood Lipid Parameters in Different Preeclampsia-Like Mouse Models,” Chinese Medical Journal 130, no. 9 (2017): 1033–1041.

[181] P. Wang, C. X. Huang, J. J. Gao, et al., “Resveratrol Induces SIRT1-Dependent Autophagy to Prevent H(2)O(2)-Induced Oxidative Stress and Apoptosis in HTR8/SVneo Cells,” Placenta 91 (2020): 11–18.

[182] M. Li, X. Wu, P. An, H. Dang, Y. Liu, and R. Liu, “Effects of Resveratrol on Autophagy and the Expression of Inflammasomes in a Placental Trophoblast Oxidative Stress Model,” Life Sciences 256 (2020): 117890.

[183] Z. Zhiqiang, Z. Chong, and Z. Yunxia, “Salvianolic Acid B Promotes the Invasion and Migration of HO-Induced HTR-8/Svneo Trophoblast Cells by Upregulating Matrix Metalloproteinase-9 the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase/Protein Kinase B Pathway,” Journal of Traditional Chinese Medicine 43, no. 3 (2023): 457–465.

[184] C. Zhang, X. Han, and X. Wang, “Mechanisms Underlying the Improvement of Preeclampsia Through Salvianolic Acid B-Regulated miRNA-155/CXCR4,” Archives of Medical Science 19, no. 2 (2023): 430–447.

[185] S. J. Jeong, J. Stitham, T. D. Evans, et al., “Trehalose Causes Low-Grade Lysosomal Stress to Activate TFEB and the Autophagy-Lysosome Biogenesis Response,” Autophagy 17, no. 11 (2021): 3740–3752.

[186] X. Tian, L. Zheng, J. Ma, Y. Xu, Y. Zhang, and Y. Pi, “Inhibition of LAMP3 Mediates the Protective Effect of Vitamin D Against Hypoxia/Reoxygenation in Trophoblast Cells,” Brazilian Journal of Medical and Biological Research 56 (2023): e12816.

[187] Y. Pi, X. Tian, J. Ma, H. Zhang, and X. Huang, “Vitamin D Alleviates Hypoxia/Reoxygenation-Induced Injury of Human Trophoblast HTR-8 Cells by Activating Autophagy,” Placenta 111 (2021): 10–18.

[188] X. Tian, S. Ma, Y. Wang, et al., “Effects of Placental Ischemia Are Attenuated by 1,25-Dihydroxyvitamin D Treatment and Associated With Reduced Apoptosis and Increased Autophagy,” DNA and Cell Biology 35, no. 2 (2016): 59–70.

[189] F. Ma, N. Ding, L. Xie, et al., “Inhibition of Autophagy via 3-Methyladenine Alleviates the Progression of Preeclampsia,” Acta Biochimica et Biophysica Sinica Shanghai 57, no. 3 (2024): 356–364.

[190] A. Li, M. Zhao, Z. Yang, et al., “6-Gingerol Alleviates Placental Injury in Preeclampsia by Inhibiting Oxidative Stress via BNIP3/LC3 Signaling-Mediated Trophoblast Mitophagy,” Frontiers in Pharmacology 14 (2023): 1243734.

[191] S. Tong, T. J. Kaitu'u-Lino, R. Hastie, F. Brownfoot, C. Cluver, and N. Hannan, “Pravastatin, Proton-Pump Inhibitors, Metformin, Micronutrients, and Biologics: New Horizons for the Prevention or Treatment of Preeclampsia,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S1157–S1170.

[192] A. Furuta, T. Shima, M. Yoshida-Kawaguchi, et al., “Chloroquine Is a Safe Autophagy Inhibitor for Sustaining the Expression of Antioxidant Enzymes in Trophoblasts,” Journal of Reproductive Immunology 155 (2023): 103–766.

[193] M. R. Seo, J. Chae, Y. M. Kim, et al., “Hydroxychloroquine Treatment During Pregnancy in Lupus Patients Is Associated With Lower Risk of Preeclampsia,” Lupus 28, no. 6 (2019): 722–730.

[194] S. Sciascia, B. J. Hunt, E. Talavera-Garcia, G. Lliso, M. A. Khamashta, and M. J. Cuadrado, “The Impact of Hydroxychloroquine Treatment on Pregnancy Outcome in Women With Antiphospholipid Antibodies,” American Journal of Obstetrics and Gynecology 214, no. 2 (2016): 273.

[195] A. Mekinian, M. G. Lazzaroni, A. Kuzenko, et al., “The Efficacy of Hydroxychloroquine for Obstetrical Outcome in Anti-Phospholipid Syndrome: Data From a European Multicenter Retrospective Study,” Autoimmunity Reviews 14, no. 6 (2015): 498–502.

[196] A. Morozova, S. C. Chan, S. Bayle, et al., “Development of Potent and Selective ULK1/2 Inhibitors Based on 7-Azaindole Scaffold With Favorable In Vivo Properties,” European Journal of Medicinal Chemistry 266 (2024): 116101.

[197] D. F. Egan, M. G. Chun, M. Vamos, et al., “Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates,” Molecular Cell 59, no. 2 (2015): 285–297.

[198] F. C. Brownfoot, R. Hastie, N. J. Hannan, et al., “Metformin as a Prevention and Treatment for Preeclampsia: Effects on Soluble Fms-Like Tyrosine Kinase 1 and Soluble Endoglin Secretion and Endothelial Dysfunction,” American Journal of Obstetrics and Gynecology 214, no. 3 (2016): 356.

[199] L. He, X. Wu, F. Zhan, X. Li, and J. Wu, “Protective Role of Metformin in Preeclampsia via the Regulation of NF-κB/sFlt-1 and Nrf2/HO-1 Signaling Pathways by Activating AMPK,” Placenta 143 (2023): 91–99.

[200] K. Onda, S. Tong, S. Beard, et al., “Proton Pump Inhibitors Decrease Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction,” Hypertension 69, no. 3 (2017): 457–468.

[201] C. A. Cluver, N. J. Hannan, E. van Papendorp, et al., “Esomeprazole to Treat Women With Preterm Preeclampsia: A Randomized Placebo Controlled Trial,” American Journal of Obstetrics and Gynecology 219, no. 4 (2018): 388.

[202] S. Jin, C. Wu, M. Chen, D. Sun, and H. Zhang, “The Pathological and Therapeutic Roles of Mesenchymal Stem Cells in Preeclampsia,” Frontiers in Medicine 9 (2022): 923334.

[203] Q. Li, L. Yin, Y. Si, C. Zhang, Y. Meng, and W. Yang, “The Bioflavonoid Quercetin Improves Pathophysiology in a Rat Model of Preeclampsia,” Biomedicine & Pharmacotherapy 127 (2020): 110122.

[204] M. Forte, S. Marchitti, M. Cotugno, et al., “Trehalose, a Natural Disaccharide, Reduces Stroke Occurrence in the Stroke-Prone Spontaneously Hypertensive Rat,” Pharmacological Research 173 (2021): 105875.

[205] Z. Huang, S. Cheng, S. Jash, et al., “Exploiting Sweet Relief for Preeclampsia by Targeting Autophagy-Lysosomal Machinery and Proteinopathy,” Experimental & Molecular Medicine 56, no. 5 (2024): 1206–1220.

[206] L. Cheng, Y. Zhu, D. Ke, and D. Xie, “Oestrogen-Activated Autophagy Has a Negative Effect on the Anti-Osteoclastogenic Function of Oestrogen,” Cell Proliferation 53, no. 4 (2020): e12789.

[207] L. Cheng, Y. Zhu, D. Ke, and D. Xie, “Correction to ‘Oestrogen-Activated Autophagy Has a Negative Effect on the Anti-Osteoclastogenic Function of Oestrogen’,” Cell Proliferation 57, no. 2 (2024): ecpr13571.

[208] J. H. Lee, Y. M. Yoon, Y. S. Han, S. K. Jung, and S. H. Lee, “Melatonin Protects Mesenchymal Stem Cells From Autophagy-Mediated Death Under Ischaemic ER-Stress Conditions by Increasing Prion Protein Expression,” Cell Proliferation 52, no. 2 (2019): e12545.

[209] Y. Zheng, S. Huang, J. Zhang, et al., “Melatonin Alleviates Vascular Endothelial Cell Damage by Regulating an Autophagy-Apoptosis Axis in Kawasaki Disease,” Cell Proliferation 55, no. 6 (2022): e13251.

[210] G. McLoughlin, “Interventions During Pregnancy to Prevent Preterm Birth: An Overview of Cochrane Systematic Reviews,” Research in Nursing & Health 43, no. 2 (2020): 206–207.

[211] J. Zhu, R. Huang, J. Zhang, W. Ye, and J. Zhang, “A Prophylactic Low-Dose Aspirin Earlier Than 12 Weeks Until Delivery Should Be Considered to Prevent Preeclampsia,” Medical Hypotheses 121 (2018): 127–130.

[212] M. E. Jones Pullins and K. A. Boggess, “Aspirin Dosage for Preeclampsia Prophylaxis: An Argument for 162-Mg Dosing,” American Journal of Obstetrics & Gynecology MFM 7, no. 1S (2025): 101620.

[213] D. Raymond and E. Peterson, “A Critical Review of Early-Onset and Late-Onset Preeclampsia,” Obstetrical & Gynecological Survey 66, no. 8 (2011): 497–506.

[214] I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero, “The “Great Obstetrical Syndromes” Are Associated With Disorders of Deep Placentation,” American Journal of Obstetrics and Gynecology 204, no. 3 (2011): 193–201.

[215] I. Aye, C. E. Aiken, D. S. Charnock-Jones, and G. Smith, “Placental Energy Metabolism in Health and Disease-Significance of Development and Implications for Preeclampsia,” American Journal of Obstetrics and Gynecology 226, no. 2S (2022): S928–S944.

[216] J. Torres-Torres, S. Espino-Y-Sosa, R. Martinez-Portilla, et al., “A Narrative Review on the Pathophysiology of Preeclampsia,” International Journal of Molecular Sciences 25, no. 14 (2024): 7569.

[217] S. M. Albogami, H. M. Al-Kuraishy, T. J. Al-Maiahy, et al., “Hypoxia-Inducible Factor 1 and Preeclampsia: A New Perspective,” Current Hypertension Reports 24, no. 12 (2022): 687–692.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.